Table 1.
n (%) | |
---|---|
Patients | 748 |
Age (years) | |
Mean (± SD) | 69.3 (± 9.1) |
Range | 41–90 |
≥ 80 | 97 (13.0) |
Sex (male/female) | 564 (75.4) / 184 (24.6) |
Asymptomatic (ipsilateral) | 262 (35.0) |
Grade of stenosis (%-NASCET) | |
High grade (≥70) | 619 (82.8) |
Moderate (50–69) | 118 (15.8) |
Low grade (<50) | 11 (1.5) |
Contralateral occlusion | 51 (6.8) |
Body-mass-index [kg/m2] (± SD, range) | 26.9 (± 4.14; 16.0–49.0) |
Diabetes mellitus | 218 (29.1) |
Hypertension | 657 (87.8) |
HLP on statin treatment | 559 (74.8) |
Smoking | 400 (53.5) |
Coronary heart disease | 297 (39.7) |
Myocardial infarction | 130 (17.4) |
Heart failure NYHA (III, IV) | 64 (8.6) |
Renal failure (NKF III, IV): | 214 (28.6) |
Atrial fibrillation | 55 (7.5) |
First-degree atrio ventricular-block | 78 (10.4) |
Family history of cardiovascular disease | 183 (24.5) |
Antiplatelet therapy | 681 (91.2) |
Eversion endarterectomy | 453 (61.0) |
Resectiona | 68 (9.1) |
Operation time (± SD, range) | 84.1 (±34.34 20.0–305.0) |
HLP hyperlipoproteinemia, NKF National Kidney Foundation, NYHA New York Heart Association heart failure scale, n number of patients, SD standard deviation
aResection is defined as any resection independent of the operation strategy used